MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
ICU Medical General and Administrative Expenses 2011-2026 | ICUI
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses ICU Medical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 639 M | 607 M | 608 M | 303 M | 284 M | 277 M | 328 M | 304 M | 89.4 M | 83.2 M | 88.9 M | 90.4 M | 84.6 M | 85.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 639 M | 83.2 M | 277 M |
Quarterly General and Administrative Expenses ICU Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 153 M | 159 M | 157 M | - | 163 M | 160 M | 158 M | - | 149 M | 151 M | 153 M | - | 153 M | 159 M | 153 M | - | 74.8 M | 73.9 M | 72.4 M | - | 70.9 M | 67.2 M | 140 M | - | 65.9 M | 67.8 M | 72.6 M | - | 76.6 M | 81.8 M | 85 M | - | 76.8 M | 85.1 M | 64.9 M | - | 22.4 M | 22.5 M | 22 M | - | 20.2 M | 20.3 M | 20.2 M | - | 21.8 M | 24.3 M | 22.5 M | - | 22.4 M | 23.2 M | 22.9 M | - | 20.2 M | 22.8 M | 20.9 M | - | 20.4 M | 19.7 M | 22.9 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 163 M | 19.7 M | 76.3 M |
General and Administrative Expenses of other stocks in the Medical instruments industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
23.2 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
2.97 B | $ 19.92 | 0.94 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
140 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
3.73 M | - | -9.52 % | $ 20.6 M | USA |
 |
Repro Med Systems
KRMD
|
20.4 M | $ 5.36 | -1.65 % | $ 244 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
62.8 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
198 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
941 M | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
671 M | - | -0.02 % | $ 16.3 B | USA |
 |
OraSure Technologies
OSUR
|
46.2 M | $ 2.74 | -1.79 % | $ 204 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
8.79 M | $ 8.65 | 3.1 % | $ 174 M | USA |
 |
Alcon
ALC
|
251 M | $ 80.83 | -0.37 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
291 M | $ 36.3 | -1.76 % | $ 1.7 B | USA |
 |
Haemonetics Corporation
HAE
|
437 M | $ 65.68 | -0.42 % | $ 3.31 B | USA |
 |
electroCore
ECOR
|
27.2 M | $ 6.88 | -3.1 % | $ 37.9 K | USA |
 |
AngioDynamics
ANGO
|
42.1 M | $ 10.13 | 1.5 % | $ 414 M | USA |
 |
InfuSystem Holdings
INFU
|
46.1 M | $ 8.1 | 0.56 % | $ 167 M | USA |
 |
STERIS plc
STE
|
1.33 B | $ 260.7 | -0.36 % | $ 25.7 B | USA |
 |
The Cooper Companies
COO
|
1.63 B | $ 80.7 | 0.41 % | $ 16.1 B | USA |
 |
Masimo Corporation
MASI
|
744 M | $ 134.15 | -1.54 % | $ 7.15 B | USA |
 |
Harvard Bioscience
HBIO
|
22.8 M | $ 0.49 | -8.67 % | $ 20.8 M | USA |
 |
Glaukos Corporation
GKOS
|
224 M | $ 117.26 | -1.52 % | $ 5.68 B | USA |
 |
Merit Medical Systems
MMSI
|
400 M | $ 80.09 | -0.19 % | $ 4.66 B | USA |
 |
Isoray
ISR
|
26.6 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
419 M | $ 148.9 | -0.06 % | $ 4.65 B | USA |
 |
LeMaitre Vascular
LMAT
|
36.3 M | $ 84.46 | 0.72 % | $ 1.9 B | USA |
 |
Intuitive Surgical
ISRG
|
2.14 B | $ 503.83 | -0.73 % | $ 179 B | USA |
 |
NeuroMetrix
NURO
|
6.33 M | - | 5.05 % | $ 9.02 M | USA |
 |
Utah Medical Products
UTMD
|
11 M | $ 60.61 | -1.69 % | $ 220 M | USA |
 |
Microbot Medical
MBOT
|
4.13 M | $ 1.82 | -2.15 % | $ 18.6 M |  Israel |
 |
Nephros
NEPH
|
8.91 M | $ 4.4 | 0.23 % | $ 45.7 M | USA |
 |
Milestone Scientific
MLSS
|
12.3 M | $ 0.3 | -1.38 % | $ 23.9 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.16 B | $ 23.08 | -1.33 % | $ 3.97 B | USA |
 |
Pro-Dex
PDEX
|
4.84 M | $ 37.95 | -3.69 % | $ 125 M | USA |
 |
Predictive Oncology
POAI
|
7.42 M | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
15.8 M | $ 13.88 | 1.91 % | $ 667 M | USA |
 |
Becton, Dickinson and Company
BDX
|
5.28 B | $ 201.3 | 0.11 % | $ 57.9 B | USA |
 |
Repligen Corporation
RGEN
|
219 M | $ 152.02 | -2.78 % | $ 8.47 M | USA |
 |
ResMed
RMD
|
739 M | $ 250.46 | -2.78 % | $ 36.6 B | USA |
 |
BioLife Solutions
BLFS
|
40.5 M | $ 21.94 | -2.85 % | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
14 M | $ 2.24 | -3.86 % | $ 181 M | USA |
 |
Retractable Technologies
RVP
|
13.6 M | $ 0.69 | -2.01 % | $ 20.7 M | USA |
 |
STAAR Surgical Company
STAA
|
89.9 M | $ 18.74 | -1.06 % | $ 921 M | USA |
 |
Teleflex Incorporated
TFX
|
995 M | $ 105.09 | -0.37 % | $ 4.92 B | USA |
 |
West Pharmaceutical Services
WST
|
338 M | $ 225.53 | -3.06 % | $ 16.5 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.6 B | $ 12.32 | 0.37 % | $ 2.5 B | USA |